← Back to guidelines
Cardiology12 papers

Liver disorder in pregnancy

Last edited: 4/15/2026

Overview

Liver dysfunction in pregnancy encompasses various conditions with significant maternal and fetal implications, including pre-eclampsia, HELLP syndrome, obstetric cholestasis, hyperemesis gravidarum, and acute fatty liver of pregnancy 1.

Diagnosis

  • Key Diagnostic Criteria: Elevated liver enzymes (bilirubin >25 μmol/l, AST >40 U/l, or GGT >35 U/l) 1.
  • Recommended Tests: Comprehensive liver function tests, complete blood count, coagulation profile, and imaging as indicated (e.g., ultrasound) 1.
  • Specific Syndromes Identified: Pre-eclampsia (elevated BP, proteinuria), HELLP syndrome (hemolysis, elevated liver enzymes, low platelets), obstetric cholestasis (pruritic rash, elevated bile acids) 1.
  • Management

  • First-Line Treatments:
  • - Pre-eclampsia: Management of blood pressure with antihypertensives (e.g., labetalol, nifedipine) 1. - HELLP Syndrome: Close monitoring, corticosteroids for fetal lung maturity, delivery if indicated 1. - Obstetric Cholestasis: Ursodeoxycholic acid (UDCA) 10-15 mg/kg/day 1.
  • Adjunctive Treatments:
  • - Hyperemesis Gravidarum: Nutritional support, intravenous fluids, antiemetic therapy (e.g., ondansetron) 1. - Acute Fatty Liver of Pregnancy: Immediate delivery, supportive care including hydration, glucose management, and monitoring for liver failure 1.

    Special Populations

  • Pregnancy: Specific conditions like pre-eclampsia (68 cases), HELLP syndrome (30 cases), and obstetric cholestasis (23 cases) are common 1.
  • Comorbidities: Management strategies may need adjustment in the presence of comorbidities like sepsis or postoperative complications, though specific guidelines are limited in the provided abstracts 1.
  • Key Recommendations

  • Prospectively monitor liver function tests in pregnant women to identify and manage liver dysfunction early (Evidence: Moderate 1).
  • Initiate urso-deoxycholic acid for obstetric cholestasis to manage pruritus and liver enzyme levels (Evidence: Moderate 1).
  • Consider timely delivery in cases of HELLP syndrome and acute fatty liver of pregnancy to mitigate maternal risks (Evidence: Moderate 1).
  • References

    1 Ch'ng CL, Morgan M, Hainsworth I, Kingham JG. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002. link

    Original source

    1. [1]
      Prospective study of liver dysfunction in pregnancy in Southwest Wales.Ch'ng CL, Morgan M, Hainsworth I, Kingham JG Gut (2002)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG